Bristol-Myers Squibb [BMY] vs Gilead Sciences [GILD] Detailed Comparison

TLDR: Quick Comparison Summary

Based on 13 vital metrics comparison: Bristol-Myers Squibb wins in 6 metrics, Gilead Sciences wins in 7 metrics, with 0 ties. Gilead Sciences appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bristol-Myers Squibb Gilead Sciences Better
P/E Ratio (TTM) 18.06 23.13 Bristol-Myers Squibb
Price-to-Book Ratio 5.67 7.15 Bristol-Myers Squibb
Debt-to-Equity Ratio 293.85 130.79 Gilead Sciences
PEG Ratio 6.89 14.82 Bristol-Myers Squibb
EV/EBITDA 7.20 11.42 Bristol-Myers Squibb
Profit Margin 11.38% 20.76% Gilead Sciences
Operating Margin 31.57% 38.49% Gilead Sciences
EBITDA Margin 31.57% 38.49% Gilead Sciences
Return on Equity 31.99% 32.65% Gilead Sciences
Return on Assets 7.24% 12.14% Gilead Sciences
Free Cash Flow $13.94B $10.31B Bristol-Myers Squibb
Dividend Yield 4.88% 2.83% Bristol-Myers Squibb
1-Year Return 21.77% 68.04% Gilead Sciences
Overview
Performance
Valuation
Financials
Short Interest
Dividends

Bristol-Myers Squibb vs Gilead Sciences Price History Comparison

Key Statistics Comparison

Loading Statistics...

Performance

Bristol-Myers Squibb vs Gilead Sciences Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...